In conclusion, our study demonstrated that in sepsis patients with T2DM, the levels of MAP, PLT, Cystatin C, HDL, and apoE available within 24 hours after admission played a critical role in MAKE30 prediction. The gene discussed is CST3; the disease is type 2 diabetes mellitus.